Related Experiment Video
Updated: May 31, 2026
Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells
Published on: February 27, 2020
A paradigm shift in EPH receptor interaction: biological relevance of EPHB6 interaction with EPHA2 and EPHB2 in
1Western University of Health Sciences, Department of Basic Medical Sciences, Pomona, CA 91766, USA.
Abstract:
EPH receptors are the largest known family of receptor tyrosine kinases characterized in humans. These proteins are involved in axon guidance, tissue organization, synaptic plasticity, vascular development and the progression of various diseases including cancer. The varied biological effects of EPH receptors are mediated in part by the expression of these proteins and their intracellular binding proteins. The ability of EPH molecules to form heterodimers within their own class has been suggested, although not exhaustively characterized. We have clarified this phenomenon by showing that EPHB6, a kinase-deficient receptor, can interact with EPHB2 in mammalian cells, and more significantly EPHB6 interacts with EPHA2. However, EPHB6 does not interact with another kinase-deficient receptor, EPHA10. The interaction between EPHB6 and EPHA2 is the first demonstration of an A-type receptor interacting with a B-type receptor. Furthermore, we correlated relative expression of EPHB6, EPHB2 and EPHA2 with non-invasive and invasive phenotypes of breast tumor cell lines. Our results indicate that tumor invasiveness-suppressing activity of EPHB6 is mediated by its ability to sequester other kinase-sufficient and oncogenic EPH receptors. These observations suggest that cellular phenotypes may, in part, be attributed to a combinatorial expression of EPH receptors and heteromeric interactions among the same class, as well as between two classes, of EPH receptors. Our results also suggest that EPHA10 may transduce signals by interacting with other kinase-sufficient receptors in a similar manner.
Insights
Eph receptor tyrosine kinases, including EPHB6, can form heterodimers. Kinase-deficient EPHB6 interacts with EPHA2, suppressing breast tumor invasiveness by sequestering oncogenic EPH receptors.
Area of Science:
- Cellular Biology
- Molecular Biology
- Biochemistry
Background:
- Eph receptors form the largest human receptor tyrosine kinase family.
- They regulate crucial cellular processes like axon guidance and development.
- Dysregulation of Eph receptors is implicated in various diseases, notably cancer.
Purpose of the Study:
- To investigate the heterodimerization of Eph receptors, specifically focusing on EPHB6.
- To determine if EPHB6 interacts with other Eph receptor family members.
- To explore the functional consequences of EPHB6 interactions in breast cancer cell lines.
Main Methods:
- Mammalian cell culture and co-immunoprecipitation assays to detect protein-protein interactions.
- Analysis of Eph receptor expression levels in breast tumor cell lines.
- Correlation of Eph receptor expression and interaction patterns with tumor invasiveness.
Main Results:
- Demonstrated that kinase-deficient EPHB6 interacts with kinase-sufficient EPHB2 and, significantly, with A-type receptor EPHA2.
- Showed EPHB6 does not interact with kinase-deficient EPHA10.
- Established the first evidence of A-type and B-type Eph receptor interaction (EPHB6-EPHA2).
- Correlated EPHB6, EPHB2, and EPHA2 expression with breast tumor phenotypes, revealing EPHB6 suppresses invasiveness.
Conclusions:
- Eph receptor heterodimerization, including between A- and B-types, is a key mechanism regulating cellular functions.
- EPHB6's tumor-suppressive role in breast cancer is mediated by sequestering oncogenic Eph receptors.
- Combinatorial expression and heteromeric interactions of Eph receptors significantly influence cellular phenotypes and disease progression.
Related Concept Videos
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
02:38Mitogens and the Cell Cycle
01:19Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...